Log In
BCIQ
Print this Print this
 

MM-D37K

  Manage Alerts
Collapse Summary General Information
Company MetaMax LLC
DescriptionInhibitor of cyclin dependent kinase 4 (CDK4) and CDK6
Molecular Target Cyclin dependent kinase 4 (CDK4) ; Cyclin dependent kinase 6 (CDK6)
Mechanism of ActionCyclin dependent kinase (CDK) inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid malignancies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today